The Himachal Pradesh Excise and Taxation Department has suspended the manufacturing licenses of two pharmaceutical firms based in Kala Amb in Sirmaur district for allegedly violating provisions of the NDPS Act and irregularities in sales.

Commissioner (State Taxes and Excise) Yunus said the MD-VI licenses of these drug companies had been suspended.

Click for more articles on Pharma Companies

While the license of Orison Pharma International was suspended in January, similar action was taken against the company’s sister concern Aqua Parenteral (manufacturing opium derivatives) last evening, he said.

On May 31, 2020, Orison Pharma was allegedly found manufacturing tablets containing tramadol, which were sold to a marketing company, in Ahmedabad without any agreement in violation of the Drugs and Cosmetics Act.

During inspection, 30 lakh tramadol tablets were seized.

NDPS ACT ‘violations’

- Orison Pharma 'illegally' sold tramadol tablets to an Ahmedabad firm in 2020.
- During a raid, 30 lakh tramadol tablets and 226 kg of raw material were seized.
- Licenses of Orison and its sister concern Aqua Parenteral suspended

Must read

Latest Notifications: NDPS Act

WHO adds this drug to Covid medicines list for severe cases

Govt issues notification on stockpiling of new drug under phase III Clinical trial

Drug alert: 27 out of 1227 samples declared as NSQ in January 2022

Gap in Price of Branded and Janaushadhi Medicine

DTAB recommendations to DCGI granting licenses under Clinical Trial

Govt issues draft notification on amendment on sale of Medical Devices

Four-side seal pouch machine introduced for Pharma Companies

Dr Reddy’s Laboratories launches generic Vasopressin injection USP

Biological E seeks extension from DCGI for its vaccine shelf life

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/02/14/licenses-of-two-pharma-companies-suspended-ndps-act/